⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

February 1, 1999Expert Opinion on Investigational Drugs

In vitro activities of quinolones

View Full Paper

Ask AI

Bookmark

Share

Abstract

atypical bacteriaGram-negative bacteriaGram-positive bacteriaminimal inhibitory concentrationsspectrum of activity

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

A. Dalhoff (1999) studied this question.

synapsesocial.com/papers/6a7ea14ee7861671be8ec636 https://doi.org/10.1517/13543784.8.2.123

View Full Paper

Ask AI

Bookmark

Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1In vitro susceptibilities of Mycoplasma pneumoniae, Mycoplasma hominis, and Ureaplasma urealyticum to sparfloxacin and PD 127391Original Research · 1991 · 49 citations
2In vitro activities of the newer beta-lactam and quinolone antimicrobial agents against Pseudomonas pseudomalleiOriginal Research · 1988 · 33 citations
3Concentration-dependent killing of antibiotic-resistant pneumococci by the methoxyquinolone moxifloxacinOriginal Research · 1997 · 47 citations
4Antimicrobial drug susceptibility of clinical isolates of Acinetobacter species (A. baumannii, A. haemolyticus, genospecies 3, and genospecies 6)Original Research · 1989 · 64 citations
5Comparative activity of trovafloxacin, alone and in combination with other agents, against gram-negative nonfermentative rodsOriginal Research · 1997 · 75 citations